England’s community prescribing rises almost 60% but costs increase only 15% in 10 years
The number of prescription items dispensed in the community in England has increased by 58.5% over 10 years, according to the Health & Social Care Information Centre’s Prescriptions Dispensed in the Community 2003-2013 report.
The report showed that more than 1.03 billion items were prescribed in 2013, which is more than double the 649.7 million prescribed in 2003.
The cost, however, has not experienced such an increase. The overall Net Ingredient Cost of prescriptions has only increased by 14.8% over the same period, rising from £7.51 billion ($12.8 billion) in 2003 to £8.63 billion in 2013.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze